mRNA-4203

mRNA-4203 · Immatics US, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for mRNA-4203, covering 2026-01-08 to 2026-01-08. Get the full timeline:

Most recent: Clinical Trial Update: ACTengine® IMA203 Combined With mRNA-4203 [Phase 1]